Boston Scientific Corporation (BSX) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Marlborough, MA, United States. Der aktuelle CEO ist Michael F. Mahoney.
BSX hat IPO-Datum 1992-05-19, 53,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $94.85B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative devices across interventional medical specialties. Operating through three primary segments—MedSurg, Rhythm and Neuro, and Cardiovascular—the company serves diverse therapeutic areas including gastrointestinal and pulmonary diagnostics, urology, cardiac rhythm management, neurostimulation, and interventional cardiology. Its comprehensive product portfolio encompasses implantable cardiac devices, ablation systems, coronary stents, peripheral vascular interventions, and oncology treatment solutions. Headquartered in Marlborough, Massachusetts, Boston Scientific has established itself as a leading provider of minimally invasive medical technologies that improve patient outcomes across multiple healthcare markets worldwide.
